These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 8986351)

  • 1. Lesions of the lateral parabrachial nucleus block the aversive motivational effects of both morphine and morphine withdrawal but spare morphine's discriminative properties.
    Nader K; Bechara A; van der Kooy D
    Behav Neurosci; 1996 Dec; 110(6):1496-502. PubMed ID: 8986351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The parabrachial nucleus: a brain stem substrate critical for mediating the aversive motivational effects of morphine.
    Bechara A; Martin GM; Pridgar A; van der Kooy D
    Behav Neurosci; 1993 Feb; 107(1):147-60. PubMed ID: 8383500
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonidine antagonizes the aversive effects of opiate withdrawal and the rewarding effects of morphine only in opiate withdrawn rats.
    Nader K; van der Kooy D
    Behav Neurosci; 1996 Apr; 110(2):389-400. PubMed ID: 8731065
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chronic exposure to morphine does not alter the neural tissues subserving its acute rewarding properties: apparent tolerance is overshadowing.
    Bechara A; van der Kooy D
    Behav Neurosci; 1992 Apr; 106(2):364-73. PubMed ID: 1317188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Separate neural substrates mediate the motivating and discriminative properties of morphine.
    Jaeger TV; van der Kooy D
    Behav Neurosci; 1996 Feb; 110(1):181-201. PubMed ID: 8652066
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Neurobiology of withdrawal motivation: evidence for two separate aversive effects produced in morphine-naive versus morphine-dependent rats by both naloxone and spontaneous withdrawal.
    Bechara A; Nader K; van der Kooy D
    Behav Neurosci; 1995 Feb; 109(1):91-105. PubMed ID: 7734084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lateral parabrachial nucleus lesions in the rat: aversive and appetitive gustatory conditioning.
    Reilly S; Trifunovic R
    Brain Res Bull; 2000 Jul; 52(4):269-78. PubMed ID: 10856824
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conditioned aversive responses produced by delayed, but not immediate, exposure to cocaine and morphine in male Sprague-Dawley rats.
    Guenther KG; Wideman CE; Rock EM; Limebeer CL; Parker LA
    Psychopharmacology (Berl); 2018 Nov; 235(11):3315-3327. PubMed ID: 30251163
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A single brain stem substrate mediates the motivational effects of both opiates and food in nondeprived rats but not in deprived rats.
    Bechara A; van der Kooy D
    Behav Neurosci; 1992 Apr; 106(2):351-63. PubMed ID: 1317187
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Naloxone-precipitated morphine withdrawal induced place aversions: effect of naloxone at 24 hours postmorphine.
    Parker LA; Joshi A
    Pharmacol Biochem Behav; 1998 Nov; 61(3):331-3. PubMed ID: 9768568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Orexins in the midline thalamus are involved in the expression of conditioned place aversion to morphine withdrawal.
    Li Y; Wang H; Qi K; Chen X; Li S; Sui N; Kirouac GJ
    Physiol Behav; 2011 Jan; 102(1):42-50. PubMed ID: 20951152
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lesions of the dorsomedial amygdala, but not the nucleus accumbens, reduce the aversiveness of morphine withdrawal in rats.
    Kelsey JE; Arnold SR
    Behav Neurosci; 1994 Dec; 108(6):1119-27. PubMed ID: 7893404
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cholecystokinin modulates the aversive component of morphine withdrawal syndrome in rats.
    Valverde O; Roques BP
    Neurosci Lett; 1998 Mar; 244(1):37-40. PubMed ID: 9578139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Distinct regulation pattern of Egr-1, BDNF and Arc during morphine-withdrawal conditioned place aversion paradigm: Role of glucocorticoids.
    García-Pérez D; Ferenczi S; Kovács KJ; Milanés MV
    Behav Brain Res; 2019 Mar; 360():244-254. PubMed ID: 30550948
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Visceral cortex lesions block conditioned taste aversions induced by morphine.
    Mackey WB; Keller J; van der Kooy D
    Pharmacol Biochem Behav; 1986 Jan; 24(1):71-8. PubMed ID: 3945668
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aversive stimulus properties of morphine: evaluation using the drug preexposure conditioned taste aversion paradigm.
    Hunt T; Spivak K; Amit Z
    Behav Neural Biol; 1985 Jul; 44(1):60-73. PubMed ID: 3834923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Naloxone blocks the aversive effects of electrical stimulation of the parabrachial complex in a place discrimination task.
    Hurtado MM; García R; Puerto A
    Neurobiol Learn Mem; 2016 Dec; 136():21-27. PubMed ID: 27660078
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptics block high- but not low-dose heroin place preferences: further evidence for a two-system model of motivation.
    Nader K; Bechara A; Roberts DC; van der Kooy D
    Behav Neurosci; 1994 Dec; 108(6):1128-38. PubMed ID: 7893405
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protein kinases in the rat nucleus accumbens are involved in the aversive component of opiate withdrawal.
    Valverde O; Tzavara E; Hanoune J; Roques BP; Maldonado R
    Eur J Neurosci; 1996 Dec; 8(12):2671-8. PubMed ID: 8996817
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Insular cortex lesions and taste aversion learning: effects of conditioning method and timing of lesion.
    Cubero I; Thiele TE; Bernstein IL
    Brain Res; 1999 Aug; 839(2):323-30. PubMed ID: 10519056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.